Log In or Create Account
CROI
Conference on Bacteriophages
RWHAP Clinical Conference
Podcasts
Slides
Question of the Week
Donate
Contact
Advanced Search
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
MATE Act CME
About Webinars
Dialogues
Upcoming IAS–USA Dialogues
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
HIV Drug Resistance
Drug Resistance Mutations Chart
Recent Webinars
Journal Articles
Fellow Resources
Fellow Resources
IAS-USA Guidelines and Recommendations
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Scientific Leadership Board
IAS-USA Leadership Award Recipients
Core Faculty
Mission
Staff
CME
Funding Information
Careers
Website Policies
Governance
FAQs
Menu
Professors
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Toby Maurer, MD
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Theodora Hatziioannou, PhD
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Tiffany Walker, MD
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Teresa Evering, MD, MS
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Tamar Ginossar, PhD
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Tami P. Sullivan, PhD
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Timothy J. Wilkin, MD, MPH
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Tonia C. Poteat, PhD, MPH, PA-C
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Todd T. Brown, MD, PhD
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Page 26 of 35
« First
«
...
10
20
...
24
25
26
27
28
...
»
Last »
CROI
Conference on Bacteriophages
RWHAP Clinical Conference
Podcasts
Slides
Question of the Week
Donate
Contact
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
MATE Act CME
About Webinars
Dialogues
Upcoming IAS–USA Dialogues
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
HIV Drug Resistance
Drug Resistance Mutations Chart
Recent Webinars
Journal Articles
Fellow Resources
Fellow Resources
IAS-USA Guidelines and Recommendations
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Scientific Leadership Board
IAS-USA Leadership Award Recipients
Core Faculty
Mission
Staff
CME
Funding Information
Careers
Website Policies
Governance
FAQs
Practice Question of the Week
April 14, 2025: Viral Suppression in the HIV Prevention Trials Network 083 Study
Of the 47 participants in the HIV Prevention Trials Network (HPTN) 083 (Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men) who were exposed to long-acting cabotegravir (CAB-LA) who became infected with HIV, what proportion achieved viral suppression on their first antiretroviral regimen?
A. 52%
B. 64%
C. 77%
D. 93%
Register for the Webinar
View Archived Questions
Leave Feedback
Subscribe
CLOSE